Research
Direct-to-consumer self-tests sold in the UK in 2023: cross sectional review of information on intended use, instructions for use, and post-test decision making
Clare Davenport, Alex Richter, Bethany Hillier, et al
BMJ 2025; 390 doi: https://doi.org/10.1136/bmj-2025-085546 (Published 23 July 2025)Cite this as: BMJ 2025;390:e085546
Abstract
Objectives To review the information provided for self-test devices sold in high street shops in the UK and to assess their suitability for informed decision making based on use, interpretation, and post-test actions.
Design Cross sectional review of information on self-test boxes and instructions for use leaflets.
Setting Supermarkets, pharmacies, and health and wellbeing shops within a 10 mile radius of the University of Birmingham’s campus at Edgbaston in 2023.
Main outcome measures Information on intended use of test, biomarker and clinical condition, interpretation of test results, recommendations for post-test actions, and coherence of intended use and post-test recommendations with evidence based guidance.
Results 30 self-tests assessing 20 biomarkers for 19 different conditions were included. Information to guide purchase was present on a few boxes: who should use the test and when (8/30, 27%), action after the test result (7/30, 23%), and numerical test performance (10/30, 33%). From the information provided either on the box or within the instructions for use leaflets, 21 (70%) self-tests were judged to be used for diagnosis and 15 (50%) to be used for screening, although 3/21 (14%) did not provide any information about symptoms and 10/15 (67%) did not provide any information about risk factors to guide use. 27 (90%) self-tests recommended follow-up with a healthcare professional if results were positive or abnormal, and 14 (47%) if test results were negative or normal. Use of tests for 11 of 19 (58%) conditions was judged contrary to evidence based guidance in one or more of the intended population, frequency of testing, test threshold, or investigative approach required for a condition.
Table 1
Test characteristics: Biomarkers, sample types, and indications for use
| Test ID label | Product name (original cost) | Sample type | Biomarker | IFU clinical claim | Indication | Associated conditions | Symptoms for diagnosis | Characteristics to screen | |
|---|---|---|---|---|---|---|---|---|---|
| T1 | Menopause Test (£14.49) | Urine | FSH | Menopausal transition phase | Not stated | 0 | 10 | 0 | |
| T2 | Flourish Menopause Test Kit (£10.00) | Urine | FSH | Under menopausal process | Not stated | 0 | 11 | 0 | |
| T3 | Menopause (FSH) Rapid Test (£4.00) | Urine | FSH | Onset of menopause | Diagnosis | 5 | 9 | 0 | |
| T4 | FSH Rapid Menopause Test Midstream (£10.00) | Urine | FSH | Onset of menopause | Diagnosis | 5 | 9 | 0 | |
| T5 | SP-10 Male Fertility Rapid Test (£12.50) | Semen | Acrosomal protein SP-10 | Low sperm concentration | Diagnosis, screening | 0 | 1 | 0 | |
| T6 | SpermCheck Fertility (£29.99) | Semen | Acrosomal protein SP-10 | Low sperm concentration/count | Screening | 0 | 0 | 0 | |
| T7 | SwimCount Sperm Quality Test (£39.99) | Semen | Progressive motile sperm cells (cells/mL) | Predictor of male fertility | Not stated | 0 | 0 | 0 | |
| T8 | SURE CHECK HIV Self-Test (£33.95) | Capillary blood | Antibodies to HIV-1 and HIV-2 | HIV infection | Screening | 1 | 0 | 1 | |
| T9 | Female Chlamydia STI Test Kit (£19.99) | Vaginal swab | Not stated | Chlamydia trachomatis | Not stated | 9 | 0 | 0 | |
| T10 | Women’s Intimate Self-test (£8.99) | Vaginal swab | Vaginal pH | Thrush, bacterial, or trichomoniasis infection | Diagnosis | 0 | 7 | 0 | |
| T11 | Canestest Self-test for Vaginal Infections (£7.50) | Vaginal swab | Vaginal pH | Bacterial vaginosis, thrush, trichomonas | Diagnosis | 2 | 1 | 0 | |
| T12 | Urine Infection Test (£14.49) | Urine | Protein, nitrite, and leucocytes | Diagnosis | 0 | 6 | 0 | ||
| T13 | Bowel Health Test (£14.49) | Faeces | Human haemoglobin | Early stages of colon cancer | Not stated | 5 | 0 | 2 | |
| T14 | FOB Rapid Test (Faeces) (£10.00) | Faeces | Human haemoglobin | Not stated | 6 | 0 | 0 | ||
| T15 | Prostate Health Test (£14.49) | Capillary blood | Prostate specific antigen | Indicator of prostate health | Not stated | 4 | 0 | 2 | |
| T16 | Stomach Ulcer Test (£14.49) | Capillary blood | Helicobacter pylori antibodies | Not stated | 3 | 2 | 0 | ||
| T17 | Gluten Sensitivity Test (£17.49) | Capillary blood | Anti-tissue transglutaminase IgA antibodies | Not stated | 2 | 9 | 0 | ||
| T18 | One step Strep A Swab test (£14.49) | Throat swab (tonsils) | Group A streptococcal antigen | Group A streptococcal infection | Diagnosis | 6 | 2 | 0 | |
| T19 | Flowflex Influenza A/B Rapid Test (Self-Testing) (£2.50) | Nasal swab | Influenza A antigen and influenza B antigen | Acute influenza type A and B viral infections | Diagnosis, screening | 2 | 9 | 0 | |
| T20 | Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing) (£1.93) | Nasal swab | SARS-CoV-2 nucleocapsid antigen | Covid-19 | Diagnosis, screening | 0 | 8 | 1 | |
| T21 | One step test for SARS-CoV-2 Antigen (Colloidal Gold) (£2.00) | Nasal swab | SARS-CoV-2 nucleocapsid antigen | SARS-CoV-2 infection | Diagnosis, screening | 0 | 7 | 1 | |
| T22 | STEPAHEAD COVID-19 Antigen Rapid Test Kit (Swab) For Self-Testing (£1.89) | Nasal swab | SARS-CoV-2 nucleocapsid antigen | SARS-CoV-2 infection | Not stated | 0 | 1 | 1 | |
| T23 | Microalbuminuria (MAU) Rapid Test Kit (Colloidal Gold) (£8.00) | Urine | Albuminuria | Diagnosis of chronic kidney injury (CKI) | Diagnosis | 4 | 0 | 0 | |
| T24 | TSH Rapid Test Cassette (£10.00) | Capillary blood | TSH | Hypothyroidism | Diagnosis, screening | 0 | 8 | 0 | |
| T25 | Ferritin Rapid Test Cassette (£8.00) | Capillary blood | Ferritin | Iron deficiency anaemia | Not stated | 8 | 12 | 0 | |
| T26 | Iron Deficiency (£8.00) | Capillary blood | Ferritin | Iron deficiency anaemia | Not stated | 4 | 5 | 0 | |
| T27 | Vitamin D Rapid Test Cassette (£8.00) | Capillary blood | 25-hydroxyvitamin D | Vitamin D deficiency | Diagnosis, screening, monitoring | 18 | 0 | 0 | |
| T28 | Vitamin D Test (£8.00) | Capillary blood | 25-hydroxyvitamin D | Vitamin D deficiency | Diagnosis, screening, monitoring | 18 | 0 | 0 | |
| T29 | Cholesterol Level Test (£14.99) | Capillary blood | Total cholesterol | Hypercholesterolemia | Not stated | 7 | 0 | 0 | |
| T30 | Blood Glucose Test (£12.99) | Capillary blood | Blood glucose | Blood sugar level | Not stated | 8 | 0 | 0 |
£1.00 (€1.16; $1.36).
FOB=faecal occult blood; FSH=follicle stimulating hormone; IFU=instructions for use; IgA=immunoglobulin A; STI=sexually transmitted infection; TSH=thyroid stimulating hormone.
Table 2
Information provided at point of sale on self-test boxes
| Test ID label | Health condition to be detected | Information about indications for testing | Biomarker stated | Advice after test | Claim about performance | Time to test result |
|---|---|---|---|---|---|---|
| T1 | Menopause | Consult doctor | Reliable | 3 minutes | ||
| T2 | Menopause | Reliable | 10 minutes | |||
| T3 | Menopause | FSH | 99% accurate | 3 minutes | ||
| T4 | Menopause | FSH | 99% accurate | 3 minutes | ||
| T5 | Male fertility | Men | Sperm count | 98% accurate | 5 minutes | |
| T6 | Male fertility | Men. Trying to conceive | Sperm count | Test every 2/3 months | Proven accurate | Minutes* |
| T7 | Sperm quality | Progressive motile sperm cells (PMSC) | Consult doctor or make lifestyle changes | 30 minutes | ||
| T8 | HIV viral infection | Not for those on antiretroviral treatment or in HIV vaccine trial | HIV infection | Confirming results with doctor | 15 minutes | |
| T9 | Chlamydia in women | Women. Do not test during menstruation, pregnancy, or recent course antibiotics | Chlamydia infection | Minutes* | ||
| T10 | Common vaginal infections | Women. One or more of itching, burning, pain when urinating, discharge, odour | Vaginal pH | Consult doctor or pharmacist | 90% accurate | 10 seconds |
| T11 | Common vaginal infections | One or more of itching, burning, pain when urinating, discharge, odour | Vaginal pH | Seek attention for treatment | 90% accurate | Seconds* |
| T12 | Urine infections | One or more of burning when urinating, frequency, cloudy urine, odour, pain, fever | Protein, nitrite, leucocytes | |||
| T13 | Symptoms of colon polyps (polyps precede bowel cancer) | |||||
| T14 | Bowel health (aid in the diagnosis of bowel cancer) | Occult blood | 90% accurate | 5 minutes | ||
| T15 | Prostate health (enlargement of the prostate, prostatitis, urinary infection, early indication of prostate cancer) | PSA | Consult GP | 10 minutes | ||
| T16 | Stomach ulcer test | H pylori | 10 minutes | |||
| T17 | Gluten sensitivity test | Symptoms | TTG | 97% accurate | 15 minutes | |
| T18 | Streptococcus A detection | Strep A | ||||
| T19 | Influenza A/B | Influenza A/B | ||||
| T20 | SARS-CoV-2 | SARS-CoV-2 | ||||
| T21 | SARS-CoV-2 | SARS-CoV-2 | ||||
| T22 | Covid-19 | Covid-19 | ||||
| T23 | None | Albumin | 98% accurate | 3 minutes | ||
| T24 | Underactive thyroid | TSH | 98% accurate | 3 minutes | ||
| T25 | Iron deficiency | Ferritin | 95% accurate | 5 minutes | ||
| T26 | Iron deficiency | Ferritin | 5 minutes | |||
| T27 | Vitamin D deficiency | Vit D | Clinically tested accuracy | 10 minutes | ||
| T28 | Vitamin D deficiency | 25-hydroxy Vit D | 10 minutes | |||
| T29 | Cholesterol level | Cholesterol level | 3 minutes | |||
| T30 | Glucose | Glucose | Minutes* |
FSH=follicle stimulating hormone; PSA=prostate specific antigen; Strep=streptococcus; TSH=thyroid stimulating hormone; TTG=tissue transglutaminase.
- * No specific duration specified.
Table 3
Test interpretation and recommended actions
| Test ID label: product name; result | Interpretation | Recommended medical contact | Treatment/actions | Further tests |
|---|---|---|---|---|
| T1: Menopause Test | ||||
| Positive | Assume that you have reached post menopause if both test results are positive | Repeat the test a week later if first is positive | ||
| Negative | You have not yet reached post-menopause | |||
| T2: Flourish Menopause Test Kit | ||||
| Positive | You could be under menopausal process if both test results are positive | Gynaecologist | Repeat the test 5-7 days later if first is positive | |
| Negative | You are probably not under menopausal process | Gynaecologist | Repeat test 40-60 days later if you still have symptoms | |
| T3: Menopause (FSH) Rapid Test | ||||
| Perimenopausal symptoms: | ||||
| Positive | Most likely (two positive test results) or may be in perimenopause (one positive test) | Doctor | Do not immediately discontinue contraception | |
| Negative | Most likely not experiencing perimenopause | Doctor | Test can be repeated | |
| Menopausal symptoms: | ||||
| Positive | Menopause has most likely occurred (after one positive test) | |||
| Negative | Repeat testing in following month if still have symptoms | |||
| T4: FSH Rapid Menopause Test Midstream | ||||
| Perimenopausal symptoms: | ||||
| Positive | Most likely (two positive test results) or may be in perimenopause (one positive test) | Doctor | Do not immediately discontinue contraception | |
| Negative | Most likely not experiencing perimenopause | Doctor | Test can be repeated | |
| Menopausal symptoms: | ||||
| Positive | Menopause has most likely occurred (one positive test) | |||
| Negative | Repeat testing in following month if still have symptoms | |||
| T5: SP-10 Male Fertility Rapid Test | ||||
| Positive | Sperm concentration is less than 15 million/mL | Expert medical advice | ||
| Negative | Sperm concentration is above 15 million/mL | |||
| T6: SpermCheck Fertility | ||||
| Positive | Sperm count concentration is less than 15 million/mL | Doctor | Possible treatment for subfertility as advised by doctor | Complete semen analysis |
| Negative | Sperm count is at least 15 million/mL | Doctor if still experiencing fertility issues | Complete semen analysis and fertility evaluation for partner | |
| T7: SwimCount Sperm Quality Test | ||||
| Positive | PMSC concentration is lower than for fertile men; may be unable to get your partner pregnant naturally | Doctor | Lifestyle changes to improve sperm concentration | Repeat test in three months after lifestyle changes |
| Negative | PMSC concentration is normal; high chance making partner pregnant naturally | Doctor if still experiencing fertility issues | ||
| T8: SURE CHECK HIV Self-Test | ||||
| Positive | Probably HIV positive | Doctor | Protect yourself and others | Confirmatory laboratory test |
| Negative | Probably HIV negative | Doctor if possibility of being in the seroconversion period | Repeat the test in 3 months if possible exposure to HIV | |
| T9: Female Chlamydia STI Test Kit | ||||
| Positive | Doctor | Sexual partner should also take a test and undergo treatment | ||
| Negative | Highly unlikely to have chlamydia | Regular testing recommended | ||
| T10: Women’s Intimate Self-test | ||||
| Positive | Vaginal pH is higher than normal; probably have bacterial vaginosis/trichomoniasis dependent on symptoms | Pharmacist if bacterial vaginosis suspected; doctor if trichomoniasis suspected | Product for bacterial vaginosis from pharmacist; treatment for trichomoniasis from doctor | |
| Negative | Vaginal pH is normal; probably have thrush if symptoms are present | Pharmacist if thrush is suspected | Products for thrush advised by pharmacist | |
| T11: Canestest Self-test for Vaginal Infections | ||||
| Positive | Vaginal pH is higher than normal; probably have bacterial vaginosis/trichomoniasis infection dependent on symptoms | Pharmacist if bacterial vaginosis suspected; doctor if trichomoniasis suspected or if no symptoms | Treatment for bacterial vaginosis from pharmacist or doctor; trichomoniasis from doctor | |
| Negative | Vaginal pH is normal; probably have thrush if symptoms are present | Pharmacist if thrush suspected | Over-the-counter thrush products | |
| T12: Urine Infection Test | ||||
| Positive | Likely that something is wrong with your urine | GP | Further investigation by GP | |
| Negative | Doctor if symptoms persist | |||
| T13: Bowel Health Test | ||||
| Positive | Blood detected in stool | Doctor | ||
| Negative | No blood detected in stool (does not exclude possibility of bowel condition) | Test yourself or arrange to be tested annually from age 40 years | ||
| T14: FOB Rapid Test (Faeces) | ||||
| Positive | Blood in faeces does not necessarily indicate colorectal bleeding | Doctor | ||
| Negative | ||||
| T15: Prostate Health Test | ||||
| Positive | PSA level is higher than normal (4 ng/mL) | Doctor | ||
| Negative | PSA level is in the normal range | Regular testing if between 50 and 75 years of family history | ||
| T16: Stomach Ulcer Test | ||||
| Positive | H. pylori antibodies detected | Doctor | ||
| Negative | No H. pylori antibodies detected | Doctor if symptoms persist | ||
| T17: Gluten Sensitivity Test | ||||
| Positive | Anti-t-TG IgA type antibodies are present | Doctor | ||
| Negative | No anti-t-TG IgA type antibodies detected | Doctor if symptoms persist | ||
| T18: One step Strep A Swab test | ||||
| Positive | May be in a stage of Strep A infection | Doctor | ||
| Negative | Concentration of Strep A antigen is zero or below detection limit (probably not infected) | Doctor if symptoms persist or experience serious complications | ||
| T19: Flowflex Influenza A/B Rapid Test (Self-Testing) | ||||
| Positive | Influenza A or B antigen detected | Alternative confirmatory tests | ||
| Negative | No influenza or A/B antigen detected (does not preclude influenza or other infections) | Alternative confirmatory tests | ||
| T20: Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing) | ||||
| Positive | Presence of SARS-CoV-2 antigen; very likely infected with covid-19 | Doctor | Follow self-isolation rules; contact local health department | PCR test |
| Negative | Unlikely to currently have covid-19; infection may still be present (does not rule out other infections) | Follow current rules | Repeat test after 1-2 days if infection suspected; molecular assay if necessary | |
| T21: One step test for SARS-CoV-2 Antigen (Colloidal Gold) | ||||
| Positive | Presence of SARS-CoV-2 antigen; likely to have covid-19 | Doctor | Follow self-isolation rules; contact local health department | Molecular testing |
| Negative | No SARS-CoV-2 antigen detected; unlikely to be infected with covid-19; there may still be an infection | Follow current rules | Repeat test after 1-2 days if infection suspected or with a molecular assay | |
| T22: STEPAHEAD COVID-19 Antigen Rapid Test Kit (Swab) For Self-Testing | ||||
| Positive | Presence of SARS-CoV-2; suspicion of covid-19 infection | Doctor | Follow self-isolation rules; contact local health department | PCR test |
| Negative | Does not preclude SARS-CoV-2 infection; there may still be an infection | Healthcare provider if still experiencing covid-like symptoms | Follow current rules | Repeat test after 1-2 days if infection suspected |
| T23: Microalbuminuria (MAU) Rapid Test Kit (Colloidal Gold) | ||||
| Positive | Albumin in urine is more than 20 mg/L (does not necessarily indicate kidney injury) | |||
| Negative | Albumin in urine is less than the cutoff value | |||
| T24: TSH Rapid Test Cassette | ||||
| Positive | TSH level is higher than normal (5 μIU/mL) (indicates an underactive thyroid (hypothyroidism)) | Physician; repeatedly abnormal results discussed with doctor | Further tests decided by physician; quantitative laboratory TSH assay | |
| Negative | TSH below 5 μIU/mL within normal range (not in range to consider hypothyroidism; hyperthyroidism cannot be excluded) | Physician if symptoms persist | Quantitative laboratory TSH assay | |
| T25: Ferritin Rapid Test Cassette | ||||
| Positive | Ferritin concentration in blood is lower than 30 ng/mL; possible iron deficiency | Physician; repeatedly abnormal results discussed with doctor | Tests decided by physician; use a secondary analytical method | |
| Negative | Ferritin higher than 30 ng/mL and within normal range; no potential iron deficiency | Physician if symptoms persist | Use a secondary analytical method | |
| T26: Iron Deficiency | ||||
| Positive | Ferritin concentration in blood is lower than 30 ng/mL; possible iron deficiency | Physician; repeatedly abnormal results discussed with doctor | Tests decided by physician; use a secondary analytical method | |
| Negative | Ferritin higher than 30 ng/mL and within normal range; no potential iron deficiency | Physician if symptoms persist | Use a secondary analytical method | |
| T27: Vitamin D Rapid Test Cassette | ||||
| Positive | Vitamin D level is less than 30 ng/mL (deficient or insufficient) | Physician if result is deficient, insufficient, or excess | Vitamin D supplements | Tests decided by physician; use a secondary analytical method |
| Negative | Vitamin D level is higher than or equal to 30 ng/mL and within normal range | Physician if symptoms persist | Use a secondary analytical method | |
| T28: Vitamin D Test | ||||
| Positive | Vitamin D level is less than 30 ng/mL (deficient or insufficient) | Physician if result is deficient, insufficient, or excess | Vitamin D supplements | Tests decided by physician; use a secondary analytical method |
| Negative | Vitamin D level is higher than or equal to 30 ng/mL and within normal range | Physician if symptoms persist | Secondary analytical method | |
| T29: Cholesterol Level Test | ||||
| Positive | Cholesterol level is probably high if above 5.2 mmol/L | Doctor | Treatment as advised by doctor | Further tests as decided by doctor |
| Negative | Cholesterol is probably normal if level is less than 5.2 mmol/L | |||
| T30: Blood Glucose Test | ||||
| Positive | Below 3.9 or above 6.1 mmol/L blood sugar level is outside the normal range | Doctor if both tests are abnormal | Repeat test on a different day; detailed assessment by doctor | |
Anti-t-TG=anti-tissue transglutaminase FOB=faecal occult blood; PMSC=progressive motile sperm cells; PCR=polymerase chain reaction; PSA=prostate specific antigen; STI=sexually transmitted infection; TSH=thyroid stimulating hormone.
Conclusions The current market for self-tests does not support consumer informed decisions about their use, interpretation of test results, and subsequent actions. Clinicians working downstream of self-tests are likely to face important challenges in incorporating the results in practice. As the use of self-tests continues to increase, improved regulatory oversight is urgently needed to protect the public and healthcare systems from misuse.